Cargando…
Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis
METHOD: We conducted a detailed literature search in Medline and Embase databases and collected relevant publications written in English before April 2020. Overall survival (OS) and disease-free survival (DFS) were the primary and secondary outcomes, respectively. Basic features of patients, hazard...
Autores principales: | Jiang, Min, Ma, Shaowei, Hua, Zhongyan, Zhao, Zhiying, Gao, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052170/ https://www.ncbi.nlm.nih.gov/pubmed/33897913 http://dx.doi.org/10.1155/2021/8839512 |
Ejemplares similares
-
Prognostic value of pretreatment anemia in patients with soft tissue sarcoma: A meta-analysis
por: Shi, Landa, et al.
Publicado: (2021) -
The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma
por: Wang, Manni, et al.
Publicado: (2019) -
Prognostic value of pretreatment systemic inflammatory markers in patients with stage I endometrial cancer
por: Ahn, Jung Hwan, et al.
Publicado: (2022) -
Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy
por: Grogg, Josias Bastian, et al.
Publicado: (2023) -
Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis
por: Liu, Gang, et al.
Publicado: (2018)